5b4w: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==Crystal structure of Plexin inhibitor complex== | ==Crystal structure of Plexin inhibitor complex== | ||
<StructureSection load='5b4w' size='340' side='right' caption='[[5b4w]], [[Resolution|resolution]] 2.60Å' scene=''> | <StructureSection load='5b4w' size='340' side='right'caption='[[5b4w]], [[Resolution|resolution]] 2.60Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5b4w]] is a 12 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5B4W OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5B4W FirstGlance]. <br> | <table><tr><td colspan='2'>[[5b4w]] is a 12 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5B4W OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5B4W FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | ||
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=DTR:D-TRYPTOPHAN'>DTR</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=DTR:D-TRYPTOPHAN'>DTR</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> | ||
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PLXNB1, KIAA0407, PLXN5, SEP ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5b4w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5b4w OCA], [http://pdbe.org/5b4w PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5b4w RCSB], [http://www.ebi.ac.uk/pdbsum/5b4w PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5b4w ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5b4w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5b4w OCA], [http://pdbe.org/5b4w PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5b4w RCSB], [http://www.ebi.ac.uk/pdbsum/5b4w PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5b4w ProSAT]</span></td></tr> | ||
</table> | </table> | ||
Line 19: | Line 20: | ||
</div> | </div> | ||
<div class="pdbe-citations 5b4w" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5b4w" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Plexin|Plexin]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | |||
[[Category: Large Structures]] | |||
[[Category: Arimori, T]] | [[Category: Arimori, T]] | ||
[[Category: Kitago, Y]] | [[Category: Kitago, Y]] |
Revision as of 13:04, 26 February 2020
Crystal structure of Plexin inhibitor complexCrystal structure of Plexin inhibitor complex
Structural highlights
Function[PLXB1_HUMAN] Receptor for SEMA4D. Plays a role in RHOA activation and subsequent changes of the actin cytoskeleton. Plays a role in axon guidance, invasive growth and cell migration.[1] [2] [3] [4] [5] [6] Publication Abstract from PubMedSemaphorin axonal guidance factors are multifunctional proteins that play important roles in immune response, cancer cell proliferation, and organogenesis, making semaphorins and their signaling receptor plexins important drug targets for various diseases. However, the large and flat binding surface of the semaphorin-plexin interaction interface is difficult to target by traditional small-molecule drugs. Here, we report the discovery of a high-affinity plexin B1 (PlxnB1)-binding macrocyclic peptide, PB1m6 (KD = 3.5 nM). PB1m6 specifically inhibited the binding of physiological ligand semaphorin 4D (Sema4D) in vitro and completely suppressed Sema4D-induced cell collapse. Structural studies revealed that PB1m6 binds at a groove between the fifth and sixth blades of the sema domain in PlxnB1 distant from the Sema4D-binding site, indicating the non-competitive and allosteric nature of the inhibitory activity. The discovery of this novel allosteric site can potentially be used to target plexin family proteins for the development of drugs that modulate semaphorin and plexin signaling. Allosteric Inhibition of a Semaphorin 4D Receptor Plexin B1 by a High-Affinity Macrocyclic Peptide.,Matsunaga Y, Bashiruddin NK, Kitago Y, Takagi J, Suga H Cell Chem Biol. 2016 Nov 17;23(11):1341-1350. doi:, 10.1016/j.chembiol.2016.09.015. Epub 2016 Oct 27. PMID:27984026[7] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
|